Collegium Pharmaceutical Announces the Appointment of Gino Santini to Board of Directors



Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce the appointment of Gino Santini to its Board of Directors. Mr. Santini most recently served as Senior Vice President of Corporate Strategy and Business Development at Eli Lilly and Company, where he led corporate strategy and long-range planning, M&A, new product licensing, innovative financing of internal development projects and the expansion of Lilly Ventures in the U.S. and China. 

"We are very pleased to have Gino join our Board of Directors at this pivotal time in the Company's history. As we progress our lead candidate, an extended-release, tamper-resistant oxycodone product for the treatment of chronic pain (COL-003), toward NDA filing, Gino 's expertise in commercialization and business development will be instrumental in assisting the Company in choosing our strategic path," said Michael Heffernan, CEO of Collegium. 

Mr. Santini recently retired after a 27-year career at Eli Lilly and Company, where he held positions of increasing responsibility, serving as Senior Vice President, Corporate Strategy and Policy; President, U.S. Operations; and President, Women's Health Business Unit. Mr. Santini is a past Chairman of the Board of the National Pharmaceutical Council and of Noble of Indiana, a nonprofit agency serving individuals with developmental disabilities in Central Indiana. In addition to Collegium, Mr. Santini currently serves on the boards of AMAG Pharmaceuticals AMAG -0.78% , Horizon Pharma HZNP +0.79% , Sorin SpA (SRN.MI) and Allena Pharmaceuticals. 

"The Company's DETERx(R) Technology has the potential to address a large unmet clinical and societal need in the use of opioids for the treatment of chronic pain. I look forward to working with the Collegium team to advance the lead product to the market," said Mr. Santini.

No comments:

Post a Comment

Superhit News

News Archive